Jason Kent

Partner
Full contact info

I build long-term relationships with my clients, guiding them through all stages of development, from startup to IPO and beyond.

Passions

Family

Fitness

Live Music

Experience

Sazerac Agrees to Acquire BuzzBallz

March 20, 2024

Cooley advised Sazerac, one of the world’s largest distilled spirits companies, on its agreement to acquire BuzzBallz, a woman-owned and family-operated distillery, winery and brewery in Texas.

Read more

Related contacts

Ben Beerle
Partner, San Francisco
Amelia Runyan Davis
Partner, Colorado
Sangitha Palaniappa
Associate, Palo Alto
Queenie Chen
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Todd Gluth
Partner, San Diego
Kathleen Goodhart
Partner, San Francisco
Len Jacoby
Partner, New York
Jason Kent
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Maricel Mojares-Moore
Special Counsel, San Francisco
Stella Sarma
Special Counsel, Brussels
Liza Hadley
Associate, Boston
Rachel F. Katz
Associate, New York
Greg Reith
Associate, Washington, DC
Patrick Sharma
Associate, Los Angeles Santa Monica
Rubin Waranch
Associate, Colorado
Andy Zachrich
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

2045 Launches and Raises 4 2 Million in PreSeed Funding

June 8, 2023

New York – June 8, 2023 – Cooley advised 2045, an exclusive membership network for influential      professionals of color, on its launch and $4.2 million pre-seed financing. Partner Jason Kent led the Cooley team advising 2045.

Benchstrength led the funding round, with AAF Management and Connecticut Innovations also participating. NBA New Orleans Pelicans player CJ McCollum also participated as an angel investor.

Porter Braswell, a former Goldman Sachs alumnus, founded 2045 to provide a platform and community to empower influential professionals of color to feel seen, heard and valued. The company fills the current market void while addressing the less than 1% of the $50 billion pledged by American companies to support Black communities – and diversity, equity and inclusion efforts – following the death of George Floyd in 2020 . 2045 will provide the necessary tools and programs to help corporations better support, retain and promote a diverse workforce.

Read more

Related contacts

Jason Kent
Partner, New York
DeVon Barnett
Associate, Washington, DC
Fraser Brown
Partner, Washington, DC

Related Practices & Industries

Mirum Pharmaceuticals – $275 Million Convertible Senior Notes Offering

April 13, 2023

Cooley advised Mirum Pharmaceuticals on its $275 million aggregate principal amount of 4.00% convertible senior notes due 2029. Mirum is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Jason Kent and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Gillon
Associate, San Diego
Stevie Yu
Associate, New York
Marjorie Roesser
Associate, San Francisco
Nicholaus E. Johnson
Associate, San Diego
Winda Fung
Associate, Los Angeles Santa Monica

Related Practices & Industries

Mirum Pharmaceuticals – $92 Million Follow-on Offering

September 7, 2022

Cooley advised the issuer for Mirum Pharmaceuticals’ $92 million follow-on offering of 4,000,000 shares of common stock at a public offering price of $23 per share. Mirum is a biopharmaceutical company developing and commercializing therapies for rare and debilitating liver diseases. Partner Jason Kent led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Nicholaus E. Johnson
Associate, San Diego
Daniel Gillon
Associate, San Diego
Barbara Mirza
Partner, Los Angeles Santa Monica
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Travere Therapeutics – $316 Million Convertible Note Offering

March 9, 2022

Cooley advised Travere Therapeutics on its $316 million offering of 2.25% convertible senior notes due 2029. Travere Therapeutics is a biopharmaceutical company developing and commercializing therapies for people living with rare diseases. Partners Jason Kent, Mischi a Marca and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Asa Henin
Special Counsel, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Timothy Nguyen
Special Counsel, San Francisco
Jackson Alldredge
Associate, Colorado

Related Practices & Industries

View more

Admissions and credentials

New York

California

Massachusetts

Rankings and accolades

Chambers USA: Corporate/M&A – New York (2021 – 2024)

Memberships and affiliations

American Bar Association (ABA)